101 related articles for article (PubMed ID: 25824739)
1. Loss of expression of cyclin d2 by aberrant DNA methylation: a potential biomarker in vietnamese breast cancer patients.
Truong PK; Lao TD; Doan TP; Le TA
Asian Pac J Cancer Prev; 2015; 16(6):2209-13. PubMed ID: 25824739
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 promoter hypermethylation signature for early detection of breast cancer in the Vietnamese population.
Truong PK; Lao TD; Doan TP; Le TA
Asian Pac J Cancer Prev; 2014; 15(22):9607-10. PubMed ID: 25520075
[TBL] [Abstract][Full Text] [Related]
3. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.
Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M
Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers.
Virmani A; Rathi A; Heda S; Sugio K; Lewis C; Tonk V; Takahashi T; Roth JA; Minna JD; Euhus DM; Gazdar AF
Int J Cancer; 2003 Nov; 107(3):341-5. PubMed ID: 14506731
[TBL] [Abstract][Full Text] [Related]
5. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
8. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.
Evron E; Umbricht CB; Korz D; Raman V; Loeb DM; Niranjan B; Buluwela L; Weitzman SA; Marks J; Sukumar S
Cancer Res; 2001 Mar; 61(6):2782-7. PubMed ID: 11289162
[TBL] [Abstract][Full Text] [Related]
9. DFNA5 promoter methylation a marker for breast tumorigenesis.
Croes L; de Beeck KO; Pauwels P; Vanden Berghe W; Peeters M; Fransen E; Van Camp G
Oncotarget; 2017 May; 8(19):31948-31958. PubMed ID: 28404884
[TBL] [Abstract][Full Text] [Related]
10. Association between promoter hypermethylation of the DACT2 gene and tumor stages in breast cancer.
Marusa Borgonio-Cuadra V; Miranda-Duarte A; Rojas-Toledo X; Garcia-Hernandez N; Alfredo Sierra-Ramirez J; Cardenas-Garcia M; Elena Hernandez-Caballero M
J BUON; 2018; 23(2):361-365. PubMed ID: 29745077
[TBL] [Abstract][Full Text] [Related]
11. 5'-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir.
Syeed N; Hussain F; Husain SA; Siddiqi MA
Asian Pac J Cancer Prev; 2012; 13(1):371-5. PubMed ID: 22502704
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of cyclin D2 gene in gastric carcinoma.
Oshimo Y; Nakayama H; Ito R; Kitadai Y; Yoshida K; Chayama K; Yasui W
Int J Oncol; 2003 Dec; 23(6):1663-70. PubMed ID: 14612939
[TBL] [Abstract][Full Text] [Related]
14. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin.
Dhillon VS; Shahid M; Husain SA
Mol Cancer; 2004 Dec; 3():33. PubMed ID: 15574200
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hung CS; Wang SC; Yen YT; Lee TH; Wen WC; Lin RK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308939
[TBL] [Abstract][Full Text] [Related]
16. Association between lifestyle factors and CpG island methylation in a cancer-free population.
Brait M; Ford JG; Papaiahgari S; Garza MA; Lee JI; Loyo M; Maldonado L; Begum S; McCaffrey L; Howerton M; Sidransky D; Emerson MR; Ahmed S; Williams CD; Hoque MO
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2984-91. PubMed ID: 19861513
[TBL] [Abstract][Full Text] [Related]
17. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
18. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.
Padar A; Sathyanarayana UG; Suzuki M; Maruyama R; Hsieh JT; Frenkel EP; Minna JD; Gazdar AF
Clin Cancer Res; 2003 Oct; 9(13):4730-4. PubMed ID: 14581343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
